Pradaxa Blood Thinner May Beat Warfarin After Bleeding Episode: Study
THURSDAY, Dec. 1, 2016 -- Use of a blood thinner is routine for many heart patients, but these drugs come with a risk of episodes of excess bleeding.
What, if any, anticoagulant (blood thinner) should these patients take after such episodes... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 1, 2016 Category: Journals (General) Source Type: news
Dabigatran superior to warfarin when anticoagulation is resumed after bleeding
(University of Pittsburgh Schools of the Health Sciences) In the first analysis of how to treat patients on anticoagulants who suffer a major bleeding event, a clinical practice that routinely gives doctors pause, while also evaluating a new drug, University of Pittsburgh researchers aim to provide much-needed guidance to clinicians trying to balance the risks of stroke versus bleeding when determining the best treatment. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 1, 2016 Category: Global & Universal Source Type: news
Dabigatran Bleed Risk With Two Statins in Study Raises Eyebrows Dabigatran Bleed Risk With Two Statins in Study Raises Eyebrows
"Both statins and anticoagulation for strokes save lives, and people should not jump to conclusions and stop their drugs" based on a single, flawed publication, an expert says.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 25, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
Irregular heartbeat drug combo may raise bleeding risk
HealthDay News A Canadian study suggests combining one blood thinner, Pradaxa, with certain statin medications may raise the odds for bleeding in atrial fibrillation patients. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 21, 2016 Category: Consumer Health News Source Type: news
Drug Combo for AFib Might Raise Bleeding Risk
Study found heightened odds when blood thinner Pradaxa was taken with one of two statin drugs (Source: WebMD Health)
Source: WebMD Health - November 21, 2016 Category: Consumer Health News Source Type: news
Drug Combo for Irregular Heartbeat Might Raise Bleeding Risk
Study found heightened odds when blood thinner Pradaxa was taken with one of two statin drugs
Source: HealthDay
Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Statins (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 21, 2016 Category: Consumer Health News Source Type: news
Drug Combo for Irregular Heartbeat Might Raise Bleeding Risk
MONDAY, Nov. 21, 2016 -- Because the irregular heartbeat known as atrial fibrillation can trigger stroke-inducing clots, many patients are prescribed a blood thinner.
But a new Canadian study suggests that combining one blood thinner, Pradaxa, with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 21, 2016 Category: Journals (General) Source Type: news
Dabigatran Antidote Fast, Effective in RE-VERSE AD: Now What? Dabigatran Antidote Fast, Effective in RE-VERSE AD: Now What?
It works, seems safe in patients with serious bleeds or needing urgent surgery, but its likely clinical impact is unclear. Some wonder, will bleeds go up as idarucizumab promotes more dabigatran use?Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 17, 2016 Category: Cardiology Tags: Cardiology News Source Type: news
Enrollment completed for RE-DUAL PCI study of 2,700 atrial fibrillation patients
(WHITECOAT STRATEGIES, LLC) The Baim Institute announces that patient enrollment into the international Phase IIIb RE-DUAL PCI study is complete. The study evaluates the safety and efficacy of dabigatran etexilate (marketed as Pradaxa ® ) in atrial fibrillation patients undergoing a percutaneous coronary intervention with stent placement. This is the first time that two dosages of a non-vitamin K antagonist oral anticoagulant already approved for stroke prevention in AF are evaluated in a dual versus triple antithrombotic regimen after PCI. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 14, 2016 Category: Global & Universal Source Type: news
rt-PA After Antagonizing Dabigatran by Idarucizumab rt-PA After Antagonizing Dabigatran by Idarucizumab
This case demonstrates the safe and successful treatment of ischemic stroke with rt-PA in a patient on dabigatran, following reversal of dabigatran with idarucizumab.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2016 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Researchers Publish Largest Observational Study To-Date Comparing Novel Oral Anticoagulants (NOACs) Pradaxa ® (dabigatran etexilate mesylate) and Rivaroxaban
(Source: Boehringer Ingelheim Press Releases)
Source: Boehringer Ingelheim Press Releases - October 5, 2016 Category: Research Source Type: news
CardioBrief: More Bleeds With Rivaroxaban in Real-World Comparison
(MedPage Today) -- More intracranial, other serious bleeds than with dabigatran in Medicare data (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 5, 2016 Category: Cardiology Source Type: news
Fewer Major Bleeds on Dabigatran vs Rivaroxaban for AF Fewer Major Bleeds on Dabigatran vs Rivaroxaban for AF
In elderly patients with nonvalvular atrial fibrillation (AF), dabigatran and rivaroxaban provide comparable protection against thromboembolic stroke but dabigatran is safer, according to a new analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2016 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa
Title: Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. PradaxaCategory: Health NewsCreated: 10/3/2016 12:00:00 AMLast Editorial Review: 10/4/2016 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 4, 2016 Category: Cardiology Source Type: news
Some Bleeding Risk Seen With Xarelto Vs. Pradaxa
But study wasn't definitive, and heart experts say both newer drugs are better than warfarin (Source: WebMD Health)
Source: WebMD Health - October 3, 2016 Category: Consumer Health News Source Type: news